IMMUNOPLUS Trademark

Trademark Overview


On Wednesday, September 13, 2023, a trademark application was filed for IMMUNOPLUS with the United States Patent and Trademark Office. The USPTO has given the IMMUNOPLUS trademark a serial number of 79384162. The federal status of this trademark filing is REGISTERED as of Tuesday, June 11, 2024. This trademark is owned by Nanjing GenScript Biotech Co., Ltd.. The IMMUNOPLUS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific, technological and medical research services, namely, the service of providing gene synthesis, oligo synthesis, cloning, protein expression, peptide synthesis and antibody production, genome modification, cell line establishment, animal model establishment, in vivo and in vitro assays; product quality testing; biochemical research and analysis; gene therapy research; dna screening for scientific research purposes; biological cloning services; biological research and analysis; medical and scientific research, namely, conducting clinical trials for others; medical research; scientific research in the field of genetics; biological research; development of gene-based medicines; research and development services in the field of antibodies
immunoplus

General Information


Serial Number79384162
Word MarkIMMUNOPLUS
Filing DateWednesday, September 13, 2023
Status700 - REGISTERED
Status DateTuesday, June 11, 2024
Registration Number7410943
Registration DateTuesday, June 11, 2024
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 26, 2024

Trademark Statements


Description of MarkThe mark consists of the stylized wording "IMMUNOPLUS".
Goods and ServicesScientific, technological and medical research services, namely, the service of providing gene synthesis, oligo synthesis, cloning, protein expression, peptide synthesis and antibody production, genome modification, cell line establishment, animal model establishment, in vivo and in vitro assays; product quality testing; biochemical research and analysis; gene therapy research; dna screening for scientific research purposes; biological cloning services; biological research and analysis; medical and scientific research, namely, conducting clinical trials for others; medical research; scientific research in the field of genetics; biological research; development of gene-based medicines; research and development services in the field of antibodies

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 18, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNanjing GenScript Biotech Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameNanjing GenScript Biotech Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameNanjing GenScript Biotech Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Thursday, November 30, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, December 13, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, December 18, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 22, 2023APPLICATION FILING RECEIPT MAILED
Friday, February 16, 2024ASSIGNED TO EXAMINER
Tuesday, February 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 26, 2024PUBLISHED FOR OPPOSITION
Wednesday, March 6, 2024NOTICE OF PUBLICATION
Tuesday, June 11, 2024REGISTERED-PRINCIPAL REGISTER
Thursday, July 11, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB